RxDoctor Payments Data

Michael Dougherty, MD

Adult Medicine · Merritt Island, FLNPI 1245735133

Payments from drug & device makers

$778in general payments, 2019–2025

Across 34 payments — averaging $22.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$274
  • AbbVie$168
  • Exact Sciences$93
  • Johnson & Johnson$74
  • Novo Nordisk$65
  • Abbott$42
  • plus $62 from 2 others

What the payments were for

  • Food & beverage$778100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$778 in reported general payments places this provider in the 60th percentile of 195 adult medicine providers in Florida.

See all adult medicine providers in Florida

Medicare billing

Part B allowed, 2024
$113,631
Medicare patients
429
Services billed
993

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide94$116,806
TrulicityDulaglutide70$88,939
HumiraAdalimumab11$74,626
MounjaroTirzepatide42$51,811
JardianceEmpagliflozin27$24,032
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$11,625
MyrbetriqMirabegron16$10,192
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$9,365
XareltoRivaroxaban11$7,315
JanuviaSitagliptin Phosphate15$7,093
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$4,103
Albuterol Sulfate HfaAlbuterol Sulfate158$4,029
Atorvastatin Calcium414$3,755
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$3,562
Rivastigmine13$3,426

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$39$140,750112 claims
Novo NordiskOzempic$65$116,80694 claims
AbbVieHumira, Synthroid$168$77,18035 claims
AstraZenecaBreztri Aerosphere$274$9,36511 claims
Johnson & JohnsonXarelto$74$7,31511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 195 adult medicine providers in Florida.

Other adult medicine in Merritt Island

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →